IP

Interparfums, Inc.

IPARConsumer DefensiveNASDAQ

Household & Personal Products

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.49B
+2.5% YoY
Net Income
$168.4M
+2.5% YoY
EBITDA
$303.9M
-0.2% YoY
Free Cash Flow
$215.2M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 18CONFIRMED RSI OversoldRSI 25.9, below 30, stock may be oversold
Jul 28 MACD Negative CrossoverHistogram -0.4424, negative momentum
About Interparfums, Inc.

Interparfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. The company carries a $3.62B market cap, placing it firmly in the mid-cap category. It operates in two segments, European Based Operations and United States Based Operations.

Where IPAR stands vs its 150-day and 200-day moving averages

As of the August 18, 2026 close, IPAR finished 11.86% above its 150-day moving average ($99.93) and 16.81% above its 200-day moving average ($95.69). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is IPAR overbought or oversold?

At the August 18, 2026 close, IPAR's RSI(14) was 25.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$3.62B
P/E (TTM)21.61
Fwd P/E21.72
EPS$5.23
Beta1.13
52W Change+8.1%
Dividend Yield2.74%
ROE19.1%
Analysis

The balance sheet looks solid with $211.3M in cash comfortably exceeding the $164.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $215.2M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 19.1% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 10.3% further supports the picture of efficient asset utilization. Revenue has grown from $1.09B (2022) to $1.49B (2025), reflecting a 37% increase over the period.

As with any equity investment, IPAR carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing IPAR's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms